| Product/ Trade Name |
Indication | Market | Launched/ Phase |
Marketing Partner |
Remarks |
|---|---|---|---|---|---|
| SUNRYTHM | Arrhythmia | Japan | 1991 | Daiichi Sankyo | The first anti-arrhythmic agent developed in Japan |
| BIOPTEN | Congenital metabolic disease | Japan | 1992 | Daiichi Sankyo | Orphan drug |
| Overseas | 2007 | BioMarin | |||
| BIOGAMMA | Mycosis fungoides | Japan | 1992 | Distribution discontinued | |
| HANP | Acute heart failure | Japan | 1995 | Daiichi Sankyo | The world's first successful production using recombinant DNA technology |
| FAROM | Bacterial infection | Japan | 1997 | Maruho | The world's first penem-type antibiotic |
| Adenoscan | Ischemic heart disease diagnostic aid adjunct | Japan | 2005 | Daiichi Sankyo | |
| Human ghrelin | Anorexia nervosa | Japan | Phase III | Daiichi Sankyo | |
| Memary | Alzheimer’s type dementia | Japan | 2011 | Daiichi Sankyo | NMDA receptor antagonist |